GPx Company
GPx is a biotech company that revolutionizes remote chronic disease management with bloodless blood tests. It is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care. The company was founded in 2020 and is based in Boston, Massachusetts.
Industry:
AI for Longevity
Headquarters:
Boston, Massachusetts, United States
Zip:
11-50
Founded Date:
2020-01-01
Employees Number:
11-50
Acquisitions Number:
5
Investors Number:
3250000
Total Funding:
3250000
Last Funding Date:
Seed
Last Funding Type:
contact@generalprognostics.com
Register and Claim Ownership